ZIE DE TABEL (1) met o.a.: Hypotheriode / B12 / Diabetis / Sjorgen
Neurology® Clinical Practice 2011;76 (Suppl 2):S6–S13
From the Department of Neurology (T.M.B.), University of Virginia,
Charlottesville; and Department of Neurology (M.L.M.), Mayo Clinic,
Rochester, MN.
Address correspondence and reprint requests to Dr. Ted M. Burns,
Department of Neurology, University of Virginia, Charlottesville, VA
22903; tmb8r@virginia.edu
Author disclosures are provided at the end of the article.
The Evaluation of Polyneuropathies
BY TED M. BURNS, MD
MICHELLE L. MAUERMANN,MD
Table 1 Important patterns of polyneuropathy with focused differentials (rare causes excluded) and proposed laboratory evaluation
Neuropathy pattern Common causes Proposed laboratory studies
Distal symmetric length-dependent neuropathy Diabetes mellitus Fasting blood glucosea
B12 deficiency B12 and methylmalonic acida
MGUS-associated neuropathy Serum protein electrophoresis and immunofixationa
Impaired fasting glucose Oral glucose tolerance testa
Charcot-Marie-Tooth PMP22 duplication,a Cx32,a PMP22 deletion, MPZ, MFN2a
Uremia Creatinine, creatinine clearance
Alcohol CBC, liver function tests
Hypothyroidism TSH
Thiamine deficiency Whole blood thiamine
Demyelinating poly(radiculo)neuropathies CMT1 PMP22 duplication, Cx32, MPZ, PMP22 deletion
AIDP CSF
CIDP/MADSAM/DADS Serum protein electrophoresis and immunofixation, CSF
MMN GM1 antibodies
HNPP PMP22 deletion
Somatic neuropathies with prominent
autonomic involvement
Diabetes mellitus Fasting blood sugar
AIDP CSF
Primary systemic amyloidosis Serum protein electrophoresis and immunofixation
Sjögren syndrome ESR, ANA, SS-A, SS-B
Vincristine toxicity None
Familial amyloidosis TTR amyloid mass spectrometry
Multifocal neuropathies Systemic and nonsystemic vasculitis CBC w/diff, CMP, ESR, ANA, CRP, CCP, PR3,
MPO, hepatitis B and C serologies, cryoglobulins,
HIV, urinalysis
Entrapment neuropathies None
MADSAM CSF
HNPP PMP22 deletion testing
Axonal polyradiculo(neuro)pathy Lyme Lyme serology and CSF
Sarcoid Serum ACE, CSF
AMAN, AMSAN CSF
West Nile Serum West Nile serology
Lymphomatous/carcinomatous meningitis CSF with cytology
Sensory neur(on)opathy Diabetes mellitus Fasting blood glucose
B12 deficiency B12 and methylmalonic acid
Sjögren syndrome ESR, ANA, SS-A, SS-B
HIV HIV serology
DADS Serum protein electrophoresis and immunofixation
Paraneoplastic Paraneoplastic antibodies
Leprosy None
Small fiber neuropathy Diabetes mellitus Fasting blood glucose
Impaired glucose tolerance Oral glucose tolerance test
Alcohol CBC, liver function tests
Sjögren syndrome ESR, ANA, SS-A, SS-B
Sarcoidosis Serum ACE
Primary systemic amyloidosis Serum protein electrophoresis and immunofixation
Familial amyloidosis TTR amyloid mass spectrometry
Fabry disease -Galactosidase
HSAN None
Abbreviations: AIDP acquired immune demyelinating polyradiculoneuropathy; AMAN acute motor axonal neuropathy; AMSAN acute motor and
sensory axonal neuropathy; CIDP chronic immune demyelinating polyradiculoneuropathy; DADS distal acquired demyelinating symmetric neuropathy;
HNPP hereditary neuropathy with liability to pressure palsies; HSAN hereditary sensory and autonomic neuropathy; MADSAM multifocal acquired
demyelinating sensory and motor neuropathy; MGUS monoclonal gammopathy of undetermined significance; MMN multifocal motor neuropathy;
TTR transthyretin-associated neuropathy.
a Recommended by American Academy of Neurology practice parameter.12
Table 2 Some medications that may cause polyneuropathy
Anti-infectious medications
Chloroquine
Dapsone
Isoniazid
Metronidazole
Nitrofurantoin
Dideoxycytidine and other nucleoside analogs
Chemotherapy and anticancer medications
Cisplatinum
Taxanes (paclitaxel and docetaxel)
Suramin
Thalidomide
Vincristine
Bortezomib
Antirheumatic and immunosuppressants
Chloroquine
Colchicine
Cardiovascular medications
Amiodarone
Hydralazine
Perhexiline
Propafenone
Psychiatric and sedatives
Disulfiram
Other medications
Pyridoxine (vitamin B6)
Phenytoin
Figure 1 A suggested construct for the approach to neuropathy, using the “what, where, when, and what setting” approach for characterizing polyneuropathy
Figure 2 Decision algorithm for use in cases of suspect hereditary polyneuropathy using family history and electrodiagnostic characterization
Gehele artikel:
http://www.neurology.org/content/76/7_S ... 6.full.pdf
